Enzinger AC, Ghosh K, Keating NL, et al. - This study was undertaken to present the US trends in opioid access among patients with poor prognosis cancer near the end-of-life. Researchers used part D data to analyze trends from 2007 to 2017 in opioid prescription fills and opioid potency (morphine milligram equivalents per day) near the end-of-life (EOL), characterized as the 30 days before death or hospice enrollment among 270,632 Medicare fee-for-service decedents with poor prognosis cancers. Administrative claims were used to assess trends in the pain-related emergency department (ED) visits near EOL. The findings revealed that opioid use among patients dying of cancer has declined substantially from 2007 to 2017. As per the findings, rising pain-related ED visits impl that EOL cancer pain management may be worsening.